Na Zhao

Na Zhao

Baylor College of Medicine

H-index: 14

North America-United States

About Na Zhao

Na Zhao, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at Baylor College of Medicine, specializes in the field of tumor biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract B047: Epigenetic reprogramming by CBP/P300 bromodomain inhibition of triple-negative breast cancer and the immune microenvironment

Abstract IA05: Leveraging preclinical models of triple negative breast cancer for translational research

CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

Abstract P2-23-01: Patient-derived xenografts allow deconvolution of single agent and combination chemotherapy responses in triple-negative breast cancer

Abstract P6-14-09: Non-canonical Wnt/Ror2 signaling regulates tumor cell invasion and dissemination in breast cancer through cell-matrix crosstalk

Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer

A Highlights from MBoC Selection: Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer

Na Zhao Information

University

Position

___

Citations(all)

1331

Citations(since 2020)

1045

Cited By

647

hIndex(all)

14

hIndex(since 2020)

14

i10Index(all)

17

i10Index(since 2020)

17

Email

University Profile Page

Google Scholar

Na Zhao Skills & Research Interests

tumor biology

Top articles of Na Zhao

Abstract B047: Epigenetic reprogramming by CBP/P300 bromodomain inhibition of triple-negative breast cancer and the immune microenvironment

Cancer Research

2024/2/1

Na Zhao
Na Zhao

H-Index: 9

Philip Jones
Philip Jones

H-Index: 7

Abstract IA05: Leveraging preclinical models of triple negative breast cancer for translational research

Cancer Research

2024/2/1

CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC

bioRxiv

2024

Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

The Journal of clinical investigation

2023/12/15

Abstract P2-23-01: Patient-derived xenografts allow deconvolution of single agent and combination chemotherapy responses in triple-negative breast cancer

Cancer Research

2023/3/1

Abstract P6-14-09: Non-canonical Wnt/Ror2 signaling regulates tumor cell invasion and dissemination in breast cancer through cell-matrix crosstalk

Cancer Research

2023/3/1

Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer

Molecular Biology of the Cell

2022/9/15

A Highlights from MBoC Selection: Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer

Molecular Biology of the Cell

2022/9/9

Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies

2022/7/1

Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer

Cancer research

2022/6/15

Single-cell analysis unveils the role of the tumor immune microenvironment and notch signaling in dormant minimal residual disease

Cancer research

2022/3/1

Downregulation of a mitochondrial micropeptide, MPM, promotes hepatoma metastasis by enhancing mitochondrial complex I activity

Molecular Therapy

2022/2/2

Abstract P145: The RNA helicase EIF4A is a therapeutic vulnerability in triple-negative breast cancer

Molecular Cancer Therapeutics

2021/12/1

Na Zhao
Na Zhao

H-Index: 9

Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition

Nature communications

2021/7/12

Noncanonical Wnt/Ror2 signaling regulates cell-matrix crosstalk to prompt directional tumor cell invasion and dissemination in breast cancer

2021/5/16

Non-canonical Wnt/Ror2 signaling status regulates cell-matrix crosstalk to prompt directional tumor cell invasion and dissemination in breast cancer

bioRxiv

2021/5/16

Chemotherapy coupled to macrophage inhibition leads to enhanced T and B cell infiltration and durable triple negative breast cancer regression

bioRxiv

2021/2/22

Synergy of chemotherapy and macrophage depletion leads to T cell memory activation and durable triple negative breast cancer regression

bioRxiv

2021/1/1

A hMTR4‐PDIA3P1‐miR‐125/124‐TRAF6 regulatory axis and its function in NF kappa B signaling and chemoresistance

Hepatology

2020/5

Ying Zhu
Ying Zhu

H-Index: 9

Na Zhao
Na Zhao

H-Index: 9

See List of Professors in Na Zhao University(Baylor College of Medicine)

Co-Authors

academic-engine